Northern Trust’s Stoke Therapeutics STOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.81M Buy
423,554
+76,890
+22% +$873K ﹤0.01% 2476
2025
Q1
$2.31M Sell
346,664
-4,124
-1% -$27.4K ﹤0.01% 2844
2024
Q4
$3.87M Buy
350,788
+11,635
+3% +$128K ﹤0.01% 2656
2024
Q3
$4.17M Buy
339,153
+56,538
+20% +$695K ﹤0.01% 2587
2024
Q2
$3.82M Buy
282,615
+21,724
+8% +$293K ﹤0.01% 2540
2024
Q1
$3.52M Buy
260,891
+3,299
+1% +$44.5K ﹤0.01% 2681
2023
Q4
$1.35M Sell
257,592
-7,781
-3% -$40.9K ﹤0.01% 3189
2023
Q3
$1.05M Sell
265,373
-2,762
-1% -$10.9K ﹤0.01% 3280
2023
Q2
$2.85M Buy
268,135
+71,354
+36% +$758K ﹤0.01% 2808
2023
Q1
$1.64M Sell
196,781
-1,735
-0.9% -$14.5K ﹤0.01% 3023
2022
Q4
$1.83M Sell
198,516
-5,199
-3% -$48K ﹤0.01% 3048
2022
Q3
$2.62M Sell
203,715
-2,086
-1% -$26.8K ﹤0.01% 2869
2022
Q2
$2.72M Buy
205,801
+19,166
+10% +$253K ﹤0.01% 2882
2022
Q1
$3.93M Buy
186,635
+251
+0.1% +$5.28K ﹤0.01% 2729
2021
Q4
$4.47M Sell
186,384
-558
-0.3% -$13.4K ﹤0.01% 2754
2021
Q3
$4.76M Sell
186,942
-10,310
-5% -$262K ﹤0.01% 2766
2021
Q2
$6.64M Buy
197,252
+10,592
+6% +$357K ﹤0.01% 2655
2021
Q1
$7.25M Sell
186,660
-13,310
-7% -$517K ﹤0.01% 2509
2020
Q4
$12.4M Buy
199,970
+5,413
+3% +$335K ﹤0.01% 2111
2020
Q3
$6.52M Buy
194,557
+4,597
+2% +$154K ﹤0.01% 2375
2020
Q2
$4.53M Sell
189,960
-11,177
-6% -$266K ﹤0.01% 2582
2020
Q1
$4.61M Buy
201,137
+83,733
+71% +$1.92M ﹤0.01% 2351
2019
Q4
$3.33M Buy
117,404
+9,508
+9% +$269K ﹤0.01% 2826
2019
Q3
$2.32M Buy
+107,896
New +$2.32M ﹤0.01% 3020